Episode 68: The New GLP1-s. A Tough Pill to Swallow for Consumer

Anne Malone, Citi’s North America Head of Equity Research, sits down with Filippo Falorni, U.S. Beverages, Household Products & Personal Care analyst, to discuss the impact GLP-1 drugs have had on the consumer sector and the potential ramifications of their availability in pill form. Their discussion ranges from changes to consumer behavior that we’ve already seen to what a much larger user base could mean for everyone from packaged-food firms to apparel companies.

This podcast contains thematic content and is not intended to be investment research. Nor does it constitute financial, economic, legal, tax or accounting advice. This...